The study showed a significant difference in renal podocalyxin expression between the negative control group and the nephrotic syndrome model group (p < 0.05) as shown in Figure 5A. In the nephrotic syndrome model group, renal podocalyxin expression was significantly decreased compared to the negative control group. This evidence concerns the gene PODXL and nephrotic syndrome.